Stock Movers Pfizer Deal; Oracle Rising on TikTok News; Alphabet and DOJ
Sep 22, 2025
Pfizer is making waves with its $4.9 billion acquisition of Metsera, aiming to enhance its weight-loss drug portfolio. Meanwhile, Oracle is trending upward as it plans to secure a new TikTok algorithm for U.S. users, collaborating closely with the government. In a contentious move, the Justice Department is pushing to break up Google's ad platform, which puts Google at odds with regulators, making a case for the potential harm of such a split. Tune in for insights on these pivotal business maneuvers!
AI Snips
Chapters
Transcript
Episode notes
Pfizer Targets Obesity Pipeline
- Pfizer agreed to buy Metsera for $47.50 per share with up to $22.50 in milestone payments, valuing the deal at $4.9 billion enterprise and up to $7.3 billion total.
- The acquisition targets monthly peptide obesity shots as Pfizer rebuilds after pandemic-era revenue declines.
Monthly Peptide Shot In Focus
- Metsera develops a once-a-month peptide injection led by Sir Stephen Bloom, aiming to compete in weight-loss therapeutics.
- Pfizer views this as a strategic rebuild amid falling vaccine and COVID-pill demand and expiring drug patents.
Prioritize Algorithm Control And Data Residency
- Ensure algorithm control and data residency are central when negotiating tech divestitures to satisfy regulators.
- Pair technical retraining with secure cloud custody to reduce national security concerns in foreign-owned apps.